Distinct receptor domains determine subtype-specific coupling and desensitization phenotypes for human beta1- and beta2-adrenergic receptors - PubMed (original) (raw)
Affiliations
- PMID: 8609905
Distinct receptor domains determine subtype-specific coupling and desensitization phenotypes for human beta1- and beta2-adrenergic receptors
G Rousseau et al. Mol Pharmacol. 1996 Apr.
Abstract
Human beta1- and beta2-adrenergic receptor (beta1 AR and beta2 AR) coupling and desensitization characteristics were compared in defined heterologous expression systems. Significant differences in the coupling efficacies of the two subtypes were found in both Chinese hamster fibroblasts and murine Ltk- fibroblasts, which were used as surrogate cell lines. At the maximal level of stimulation with the nonselective beta-adrenergic agonist isoproterenol, beta1 AR-mediated adenylyl cyclase activation represented 70% and 20% of that mediated by beta2 AR in Chinese hamster and murine Ltk- fibroblasts, respectively. Sustained (15 min) stimulation with subsaturating concentration of isoproterenol (< 10% of receptor occupancy) led to identical desensitization of the beta-adrenergic-stimulated adenylyl cyclase activity for both beta1 AR and beta2AR-expressing cells. In contrast, when a nearly saturating concentration of isoproterenol (> 90% of receptor occupancy) was used to promote desensitization, the extent of desensitization observed for beta2 AR-expressing cells was 1.7-2-fold higher than that of the beta1 AR. The carboxyl domain of several G protein-coupled receptors has been shown to play important roles in both coupling efficacy and agonist-promoted desensitization. Therefore, we examined the contribution of this receptor domain in the subtype-selective phenotypes described above. A chimeric receptor composed of the first six transmembrane domains of the beta1 AR and of the seventh transmembrane domain and carboxyl tail of the beta2 AR maintained a coupling efficacy characteristic of the beta1 AR, whereas the extent of desensitization resulting from high receptor occupancy was identical to that of the beta2 AR. These results therefore suggest that the carboxyl portion of the beta1 AR and beta2 AR determines their subtype-selective desensitization patterns but not their respective coupling efficacies.
Similar articles
- Cellular characterization of the pharmacological selectivity and tachyphylactic properties of denopamine for the human beta adrenergic receptors.
Suzuki T, Nantel F, Bonin H, Valiquette M, Bouvier M. Suzuki T, et al. J Pharmacol Exp Ther. 1993 Nov;267(2):785-90. J Pharmacol Exp Ther. 1993. PMID: 7902433 - Role of specific protein kinase C isoforms in modulation of beta1- and beta2-adrenergic receptors.
Guimond J, Mamarbachi AM, Allen BG, Rindt H, Hébert TE. Guimond J, et al. Cell Signal. 2005 Jan;17(1):49-58. doi: 10.1016/j.cellsig.2004.05.012. Cell Signal. 2005. PMID: 15451024 - The human beta 3-adrenergic receptor is resistant to short term agonist-promoted desensitization.
Nantel F, Bonin H, Emorine LJ, Zilberfarb V, Strosberg AD, Bouvier M, Marullo S. Nantel F, et al. Mol Pharmacol. 1993 Apr;43(4):548-55. Mol Pharmacol. 1993. PMID: 8386307 - Distinct beta-adrenergic receptor subtype signaling in the heart and their pathophysiological relevance.
Zheng M, Han QD, Xiao RP. Zheng M, et al. Sheng Li Xue Bao. 2004 Feb 25;56(1):1-15. Sheng Li Xue Bao. 2004. PMID: 14985822 Review. - Review of mechanisms involved in the apparent differential desensitization of beta1- and beta2-adrenoceptor-mediated functional responses.
Broadley KJ. Broadley KJ. J Auton Pharmacol. 1999 Dec;19(6):335-45. doi: 10.1111/j.1365-2680.1999.tb00006.x. J Auton Pharmacol. 1999. PMID: 10961739 Review.
Cited by
- The functional significance of genetic variation within the beta-adrenoceptor.
Sandilands AJ, O'Shaughnessy KM. Sandilands AJ, et al. Br J Clin Pharmacol. 2005 Sep;60(3):235-43. doi: 10.1111/j.1365-2125.2005.02438.x. Br J Clin Pharmacol. 2005. PMID: 16120061 Free PMC article. Review. - Identification of the endophilins (SH3p4/p8/p13) as novel binding partners for the beta1-adrenergic receptor.
Tang Y, Hu LA, Miller WE, Ringstad N, Hall RA, Pitcher JA, DeCamilli P, Lefkowitz RJ. Tang Y, et al. Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12559-64. doi: 10.1073/pnas.96.22.12559. Proc Natl Acad Sci U S A. 1999. PMID: 10535961 Free PMC article. - Human beta1-adrenergic receptor is subject to constitutive and regulated N-terminal cleavage.
Hakalahti AE, Vierimaa MM, Lilja MK, Kumpula EP, Tuusa JT, Petäjä-Repo UE. Hakalahti AE, et al. J Biol Chem. 2010 Sep 10;285(37):28850-61. doi: 10.1074/jbc.M110.149989. Epub 2010 Jun 29. J Biol Chem. 2010. PMID: 20587416 Free PMC article. - Determinants Present in the Receptor Carboxy Tail Are Responsible for Differences in Subtype-Specific Coupling of beta-Adrenergic Receptors to Phosphoinositide 3-Kinase.
Simard J, Boucher M, Massé R, Hébert TE, Rousseau G. Simard J, et al. Int J Cell Biol. 2009;2009:959168. doi: 10.1155/2009/959168. Epub 2009 Feb 5. Int J Cell Biol. 2009. PMID: 20130777 Free PMC article. - A macromolecular complex of beta 2 adrenergic receptor, CFTR, and ezrin/radixin/moesin-binding phosphoprotein 50 is regulated by PKA.
Naren AP, Cobb B, Li C, Roy K, Nelson D, Heda GD, Liao J, Kirk KL, Sorscher EJ, Hanrahan J, Clancy JP. Naren AP, et al. Proc Natl Acad Sci U S A. 2003 Jan 7;100(1):342-6. doi: 10.1073/pnas.0135434100. Epub 2002 Dec 26. Proc Natl Acad Sci U S A. 2003. PMID: 12502786 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials